Search results
Johnson & Johnson (NYSE:JNJ) Position Reduced by Main Street Financial Solutions LLC
ETF DAILY NEWS· 3 days agoMain Street Financial Solutions LLC lowered its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.6% during the fourth quarter, according to its most recent Form 13F filing ...
Brady Family Wealth LLC Acquires 734 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 3 days agoBrady Family Wealth LLC grew its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 1.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission ...
MainStreet Investment Advisors LLC Cuts Stock Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 3 days agoMainStreet Investment Advisors LLC trimmed its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 2.7% during the 4th quarter, according to its most recent filing with the Securities ...
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 4 days agoWASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...
Studies Show Linked Biological Pathways Driving Skin Inflammation
WFRV 5 Green Bay· 4 days agoA certain biological pathway, a set of linked reactions in the body, drives the inflammation seen in the skin disease psoriasis, a new study finds. The work could lead to improved therapies ...
Robeco Institutional Asset Management B.V. Sells 501,987 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 1 day agoRobeco Institutional Asset Management B.V. reduced its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 41.0% during the fourth quarter, according to its most recent 13F filing with the ...
AltruBio, after tweaking checkpoint drug, raises $225M for midphase ulcerative colitis program
FierceBiotech· 3 days agoAltruBio has roared back after another pivot in its twisty history, securing up to $225 million in series B funding to take an immune checkpoint enhancer through a midphase ulcerative colitis ...
Securian Asset Management Inc. Sells 20,342 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoSecurian Asset Management Inc. lowered its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 11.8% during the fourth quarter, according to the company in its most recent Form 13F filing ...
Allegheny Financial Group LTD Increases Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoAllegheny Financial Group LTD boosted its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 2.3% during the fourth quarter, according to the company in its most recent Form ...
Johnson & Johnson (NYSE:JNJ) Shares Bought by BI Asset Management Fondsmaeglerselskab A S
ETF DAILY NEWS· 3 days agoBI Asset Management Fondsmaeglerselskab A S lifted its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 59.0% in the 4th quarter, according to the company in its most recent 13F filing ...